Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin+ foam cell differentiation in the prostate
P. Popovics, K. O. Skalitzky, E. Schroeder, A. Jain, S. V. Silver, F. Van Fritz, K. S. Uchtmann, C. M. Vezina, W. A. Ricke
Abstract
Benign Prostatic Hyperplasia (BPH) occurs progressively with aging in men and drives deteriorating symptoms collectively known as Lower Urinary Tract Symptoms (LUTS). Age associated changes in circulating steroid hormones, and prostate inflammation have been postulated in the etiology of BPH/LUTS. The link between hormones and inflammation in the development of BPH/LUTS is conflicting because they may occur independently or as sequential steps in disease pathogenesis. This study aimed to decipher the prostatic immune landscape in a mouse model of lower urinary tract dysfunction (LUTD). Steroid hormone imbalance was generated by the surgical implantation of testosterone (T) and estradiol (E2) pellets to male C57BL/6J mice and gene expression analysis was performed on ventral prostates (VP). These experiments identified an increase in the expression of macrophage markers and Spp1/osteopontin (OPN). Localization studies of OPN pinpointed that OPN+ macrophages travel to the prostate lumen and transition into lipid accumulating foam cells. We also observed a significantly increased number of tissue macrophages in the VP which was prevented in OPN knockout (OPN-KO) mice. In contrast, mast cells, but not macrophages, were significantly elevated in the dorsal prostate of T+E2 treated mice which was diminished in OPN-KO mice. Steroid hormone implantation progressively increased urinary frequency, which was ameliorated in OPN-KO mice. Our study underscores the role of age associated steroid hormone imbalances as a mechanism of expanding the prostatic macrophage population, their luminal translocation and foam cell differentiation.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE
Samara V. Silver, Kayah J. Tucker, … Petra Popovics·Scientific ReportsPeer-reviewed·Sep 9, 2024
- Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia
P. Popovics, W. N. Awadallah, … M. M. Grabowska·bioRxiv·Dec 23, 2019
- Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia
Nadia A. Lanman, Era Meco, … Renee E. Vickman·Frontiers in ImmunologyPeer-reviewed·Jan 10, 2025
- Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction
G. Pattabiraman, A. J. Bell-Cohn, … P. Thumbikat·bioRxiv·Mar 23, 2021
- Immune dysregulation in the prostates of C57BL/6Aire-/- mice mirrors that seen in human benign prostatic hyperplasia
Nadia A. Lanman, Meaghan Maureen Broman, … Timothy L. Ratliff·The Journal of PathologyPeer-reviewed·Jul 8, 2026
- Assortment of Stauntonia hexaphylla and Cornus officinalis protect against testosterone-induced benign prostatic hyperplasia through anti-inflammatory and anti-proliferative activity
J. Y. Jung, S. S. L. Karunasagara, … K. H. Kim·bioRxiv·Oct 25, 2019